WHO launches training program to strengthen Syria’s disease surveillance
New cohort equips public health professionals with outbreak response, data analysis and artificial intelligence skills to improve early detection of infectious diseases

New cohort equips public health professionals with outbreak response, data analysis and artificial intelligence skills to improve early detection of infectious diseases


Study will investigate whether a GIP/GLP-1 dual receptor agonist, currently approved for type 2 diabetes, obesity and obstructive sleep apnea, can reduce symptoms of long COVID.

The Sick Times


Nova Southeastern University and the Schmidt Initiative for Long Covid will study the efficacy of a long-acting antibody for treating Long Covid